Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
This study is ongoing, but not recruiting participants.
Sponsor:
Cheryl Rosenfeld, DO
Collaborator:
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Cheryl Rosenfeld, DO, North Jersey Endocrine Consultants, LLC
ClinicalTrials.gov Identifier:
NCT01137695
First received: June 3, 2010
Last updated: October 13, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2012 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |